The Market for Rx to OTC Switches
30-Jul-2011 | News-Press Release
Manufacturers are expected to switch prescription drugs to over the counter status where possible. In the early part of the last decade there was a delcine in Rx to switches, since 2006 there has been a number of uses of this tactic to extend revenue of pharmaceutical products. In Kalorama Information's Market for Rx to OTC Switches, we take a look at recent swtiches, products that may switch in the future, and categories that can benefit most from an OTC product.
The U.S. market for Rx-to-OTC Switches encompasses a wide variety of products that have been determined safe and effective as over-the-counter products. The market is fueled by several factors including an aging population; steady to increased incidences of conditions and diseases; new drug classes switched to OTC; product demand; economic conditions and several other factors.
All product areas contribute to the growth and development of the OTC market; however, new product development and additional regulatory review and approval of new OTC drug classifications, specifically in areas such as gastrointestinal drugs, cholesterol-reducing drugs, and contraceptives are expected to make the most impact for continued growth.
As part of its coverage, this report includes
Current Market for Rx to OTC across major categories
Past Results of OTC Switches
Products Most Likely to Switch to OTC
Assessment of the Economic Situation
The U.S. Market for Rx-to-OTC Switches focuses on several treatment segments in which Rx-to-OTC switches are available:
Allergy, Cough, Cold, and Sinus Products
Analgesics, NSAIDs, and Pain Treatments
Anti-Infectives
Gastrointestinal Drugs
Oral Care
Smoking Cessation
Other Drugs, including:
Dental Rinses and Fluorides
Hair Growth Products
Rectal Ointments
Sleep Aids
Weight Management
Hormone Replacement
For more information kindly visit :
http://www.bharatbook.com/detail.asp?id=169570&rt=The-Market-for-Rx-to-OTC-Switches.html
Related Reports
CytRx Corporation-Deals & Alliances Report
http://www.bharatbook.com/detail.asp?id=136652&rt=CytRx-Corporation-Deals-Alliances-Report.html
Hemispherx Biopharma Inc-Deals & Alliances Report
http://www.bharatbook.com/detail.asp?id=136706&rt=Hemispherx-Biopharma-Inc-Deals-Alliances-Report.html
This release was submitted by a PRSafe user.
Any communication related to the content of this release should be sent to the release submitter.
Author Info
Tag Cloud
Categories
More Releases
- Research on Global and China Epoxy Resin Industry Chain Report
- The Geothermal Energy Market 2012-2022
- Adhesives and Sealants: Global Markets
- Dermatological Drugs: World Market Prospects 2012-2022
- The Electric and Range Extended Electric Light-Vehicle Report
- India Urban & Industrial Waste to Energy Market
- Understanding Russia's Regional Health Markets
- 2012 Deep Research Report on China Wind Bearing Industry
- Top 1000 Advertising Agents (European)
- HNWI Asset Allocation in Switzerland to 2016